The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol. (2021)

First Author: Ursprung S
Attributed to:  Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-021-08965-4

PubMed Identifier: 34794412

Publication URI: http://europepmc.org/abstract/MED/34794412

Type: Journal Article/Review

Volume: 21

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407